Sandbox cerebral palsy: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
Aditya Ganti (talk | contribs) |
||
| Line 20: | Line 20: | ||
**During stress, there is acid hypersecretion; therefore, the breakdown of mucosal defenses leads to injury of the mucosa and subsequent bleeding. | **During stress, there is acid hypersecretion; therefore, the breakdown of mucosal defenses leads to injury of the mucosa and subsequent bleeding. | ||
**Mucosal defects along with dilated and tortuous vessels in dieulafoy lesion put them at risk for rupture because of necrosis of the arterial wall from exposure to gastric acid. | **Mucosal defects along with dilated and tortuous vessels in dieulafoy lesion put them at risk for rupture because of necrosis of the arterial wall from exposure to gastric acid. | ||
{{familytree/start}} | |||
{{familytree | | | | | | | | | | A01 | | | | | |A01=NSAIDS}} | |||
{{familytree | | | | | | | | | | |!| | | | | | | | }} | |||
{{familytree | | | | | | | | | | A01 | | | | | |A01=Inhibits cycloxygenase pathway}} | |||
{{familytree | | | | | | | | | | |!| | | | | | | | }} | |||
{{familytree | | | | | |,|-|-|-|-|^|-|-|-|-|-|.| | | }} | |||
{{familytree | | | | | B01 | | | | | | | | | B02 |B01=COX-1|B02=COX-2}} | |||
{{familytree | | | | | |!| | | | | | | | | | |!| | | }} | |||
{{familytree | |,|-|-|-|+|-|-|-|.| | | |,|-|-|^|-|-|-|.| }} | |||
{{familytree | C01 | | C02 | | C03 | | C04 | | | | | C05 | |C01=Reduced<br>mucosal blood flow|C02=Reduced<br> mucosal and<br> bicarbonate secreation|C03=Impaired<br>platelet aggregation|C04=Reduced<br>angiogenesis|C05=Increased<br>leucocyte adherence|}} | |||
{{familytree | |!| | | |!| | | |!| | | |!| | | | | | |!| | | }} | |||
{{familytree | |`|-|-|-|^|-|-|-|+|-|-|-|^|-|-|-|-|-|-|'| | | }} | |||
{{familytree | | | | | | | | | |!| | | | | | | | | | | | | | }} | |||
{{familytree | | | | | | | | | E01 | | | | | | | | | | | | |E01=Impaired defence<br>Impaired healing}} | |||
{{familytree | | | | | | | | | |!| | | | | | | | | | | | | | }} | |||
{{familytree | | | | | | | | | F01 | | | | | | | | | | | | |F01=Mucosal Injury}} | |||
{{familytree/end}} | |||
{{familytree/start}} | {{familytree/start}} | ||
| Line 44: | Line 60: | ||
{{familytree | | | | | | | | | | C01 | | | | C02 | | | | C03 | | |C01=C01|C02=C02|C03=C03}} | {{familytree | | | | | | | | | | C01 | | | | C02 | | | | C03 | | |C01=C01|C02=C02|C03=C03}} | ||
{{familytree/end}} | {{familytree/end}} | ||
==Pathogenesis of Crohns disease== | |||
Revision as of 17:56, 18 December 2017
Pathophysiology
Mucosal barrier
- The gastric mucosa is protected from the acidic environment by mucus, bicarbonate, prostaglandins, and blood flow.
- This mucosal barrier consists of three protective components which include:
- Layer of epithelial cells lining.
- Layer of mucus, secreted by surface epithelial cells and Foveolar cells.
- Bicarbonate ions, secreted by the surface epithelial cells.
Mechanism of Action
- The insoluble mucus forms a protective gel-like coating over the entire surface of the gastric mucosa.
- The mucus protects the gastric mucosa from autodigestion by e.g. pepsin and from erosion by acids and other caustic materials that are ingested.
- The bicarbonate ions act to neutralize harsh acids.
- If the balance of gastric acid secretion and mucosal defenses is disrupted, acid interacts with the epithelium to cause damage
Pathogenesis
- Regardless of etiology, if the balance of gastric acid secretion and mucosal defenses is disrupted, acid interacts with the epithelium to cause damage.
- Helicobacter pylori disrupts the mucosal barrier and causes inflammation of the mucosa of the stomach and duodenum.
- As the ulcer progresses beyond the mucosa to the submucosa the inflammation causes weakening and necrosis of arterial walls, leading to pseudoaneurysm formation followed by rupture and hemorrhage.
- NSAIDs inhibit cyclooxygenase, leading to impaired mucosal defenses by decreasing mucosal prostaglandin synthesis.
- During stress, there is acid hypersecretion; therefore, the breakdown of mucosal defenses leads to injury of the mucosa and subsequent bleeding.
- Mucosal defects along with dilated and tortuous vessels in dieulafoy lesion put them at risk for rupture because of necrosis of the arterial wall from exposure to gastric acid.
| NSAIDS | |||||||||||||||||||||||||||||||||||||||||||||||
| Inhibits cycloxygenase pathway | |||||||||||||||||||||||||||||||||||||||||||||||
| COX-1 | COX-2 | ||||||||||||||||||||||||||||||||||||||||||||||
| Reduced mucosal blood flow | Reduced mucosal and bicarbonate secreation | Impaired platelet aggregation | Reduced angiogenesis | Increased leucocyte adherence | |||||||||||||||||||||||||||||||||||||||||||
| Impaired defence Impaired healing | |||||||||||||||||||||||||||||||||||||||||||||||
| Mucosal Injury | |||||||||||||||||||||||||||||||||||||||||||||||
| A01 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| A02 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| A02 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| B01 | B02 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| C01 | C02 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| D01 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| E01 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| B01 | B02 | B03 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| C01 | C02 | C03 | |||||||||||||||||||||||||||||||||||||||||||||||||||